Sensitive high-performance liquid chromatographic method for the determination of 2-phenylethylamine in human urine

Journal of Chromatography B: Biomedical Applications

Volumn 681, Issue 1, 1996, Pages 185-190

  La Croix, R ^a   Dostert, P ^a   Strolin Benedetti, M ^a  

^a PFIZER INC   (United States)

Author keywords

2 Phenylethylamine

Indexed keywords

CABERGOLINE; DRUG METABOLITE; MONOAMINE OXIDASE B INHIBITOR; PHENETHYLAMINE; SELEGILINE;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DERIVATIZATION; DRUG DETERMINATION; DRUG URINE LEVEL; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TECHNIQUE;

EID: 0029899204     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4347(95)00521-8     Document Type: Conference Paper

References (22)

1. E.E. Inwang, A.D. Mosnaim and H.C. Sabelli, J. Neurochem., 20 (1973) 1469.
2. S.R. Philips, B. Rozdilsky and A.A. Boulton, Biol. Psychiatry, 13 (1978) 51.
3. G.P. Reynolds and D.O. Gray, Clin. Chim. Acta, 70 (1976) 213.
4. D.A. Durden and S.R. Philips, J. Neurochem., 34 (1980) 1725.
5. I.A. Paterson, A.V. Juorio and A.A. Boulton, J. Neurochem., 55 (1990) 1827.
6. E. Fischer, H. Spatz, J.M. Saavedra, H. Reggiani, A.H. Mirò and B. Heller, Biol. Psychiatry, 5 (1972) 139.
7. M. Sandler, C.R.J. Ruthven, B.L. Goodwin and A. Coppen, Clin. Chim. Acta, 93 (1979) 169.
8. F. Karoum, S. Potkin, L.W. Chuang, D.L. Murphy, M.R. Liebowitz and R.J. Wyatt, Biol. Psychiatry, 19 (1984) 165.
9. J.D. Elsworth, V. Glover, G.P. Reynolds, M. Sandler, A.J. Lees, P. Phuapradit, K.M. Shaw, G.M. Stern and P. Kumar, Physiopharmacology, 57 (1978) 33.
10. G.P. Reynolds, P. Riederer and M. Sandler, Biochem. Soc. Trans., 7 (1979) 143.
11. H. Yang and N.H. Neff, J. Pharmacol. Exp. Ther., 187 (1973) 365.
12. C. Thorton, C.J. Doré, J.D. Elsworth, M. Herbert and G.M. Stern, Psychopharmacology, 70 (1980) 163.
13. C.T. Dollery, D.S. Davies, M. Barrow, S.M. Murray and M. Strolin Benedetti, in K.F. Tipton, P. Dosiert and M. Strolin Benedetti (Editors), Monoamine Oxidase and Disease -Prospects for Therapy with Reversible Inhibitors, Academic Press, London, 1984, p. 83.
14. D.A. Durden, S.R. Philips and A.A. Boulton, Can. J. Biochem., 51 (1973) 995.
15. J. Willner, H.F. LeFevre and E. Costa, J. Neurochem., 23 (1974) 857.
16. F. Karoum, H. Nasrallah, S. Potkin, L. Chuang, J. Mayer-Schwing, I. Phillips and R.J. Wyatt, J. Neurochem., 33 (1979) 201.
17. O. Suzuki and H. Hattori, Biomed. Mass Spectrom., 10 (1983) 430.
18. K. Hayakawa, K. Hasegawa, N. Imaizumi, O.S. Wong and M. Miyazaki, J. Chromatogr., 464 (1989) 343.
19. M. Roth, Anal. Chem., 43 (1971), 880.
20. F. Cheng, J. Kuo, Y. Shihi, J. Laùi, D. Ni and L. Chia, J. Chomatogr., 615 (1993) 225.
21. V. Barkholt and A.L. Jensen, Anal. Biochem., 177 (1989) 318.
22. P. Dostert, G. Dordain, M. Strolin Benedetti, D. Vernay, R. La Croix, D. Defford and A. Dubini, Recent Advances in the Treatment of Neurodegenerative Disorders and Cognitive Disfunction, CINP Meeting (President's workshop), Capri, Italy, May 1-3 1993, Book of Abstracts, p. 140.